AC IMMUNE

ac-immune-logo

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines to address a broad spectrum of neurodegenerative indications

#SimilarOrganizations #People #Financial #Event #Website #More

AC IMMUNE

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2003-01-01

Address:
Lausanne, Vaud, Switzerland

Country:
Switzerland

Website Url:
http://www.acimmune.com

Total Employee:
51+

Status:
Active

Contact:
+41 21 345 91 21

Email Addresses:
info@acimmune.com

Total Funding:
167.49 M USD

Technology used in webpage:
Euro Pound Sterling Microsoft Japanese Yen Microsoft Azure Akamai Hosted Comodo SSL Comodo PositiveSSL Comodo PositiveSSL Wildcard Microsoft Azure France Central Region


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

alnylam-pharmaceuticals-logo

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

inovio-pharmaceuticals-logo

Inovio Pharmaceuticals

Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.


Current Advisors List

martin-velasco_image

Martin Velasco Board of Directors @ AC Immune
Board_member

hans-gürtler_image

Hans Gürtler Board of Directors @ AC Immune
Board_member

not_available_image

F. van Leuven Scientific Advisory Board @ AC Immune
Advisor

not_available_image

Roscoe Brady Scientific Advisory Board @ AC Immune
Advisor

christof-hettich_image

Christof Hettich Member of the Board of Directors @ AC Immune
Board_member

detlev-riesner_image

Detlev Riesner Board of Directors @ AC Immune
Board_member

jean-marie-lehn_image

Jean-Marie Lehn Scientific Advisory Board @ AC Immune
Advisor

mathias-hothum_image

Mathias Hothum Board of Directors @ AC Immune
Board_member

Current Employees Featured

andreas-muhs_image

Andreas Muhs
Andreas Muhs CSO @ AC Immune
CSO

marie-kosco-vilbois_image

Marie Kosco-Vilbois
Marie Kosco-Vilbois Chief Scientific Officer @ AC Immune
Chief Scientific Officer
2019-01-01

jean-fabien-monin_image

Jean-Fabien Monin
Jean-Fabien Monin Chief Administrative Officer (CAO) @ AC Immune
Chief Administrative Officer (CAO)
2015-07-01

andrea-pfeifer_image

Andrea Pfeifer
Andrea Pfeifer Co-Founder & CEO @ AC Immune
Co-Founder & CEO
2003-02-01

wolfgang-barth_image

Wolfgang Barth
Wolfgang Barth Director of Development @ AC Immune
Director of Development

Founder


andrea-pfeifer_image

Andrea Pfeifer

Stock Details


Company's stock symbol is NASDAQ:ACIU

Investors List

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Post-IPO Equity - AC Immune

redmile-group_image

Redmile Group

Redmile Group investment in Post-IPO Equity - AC Immune

stempoint-capital_image

StemPoint Capital

StemPoint Capital investment in Post-IPO Equity - AC Immune

avidity-partners_image

Avidity Partners

Avidity Partners investment in Post-IPO Equity - AC Immune

dietmar-hopp_image

Dietmar Hopp

Dietmar Hopp investment in Series E - AC Immune

dievini-hopp-biotech-holding_image

dievini Hopp Biotech Holding

dievini Hopp Biotech Holding investment in Series D - AC Immune

Official Site Inspections

http://www.acimmune.com Semrush global rank: 3.61 M Semrush visits lastest month: 3.54 K

  • Host name: od-c8532b.infomaniak.ch
  • IP address: 83.166.155.136
  • Location: Switzerland
  • Latitude: 47.1449
  • Longitude: 8.1551
  • Timezone: Europe/Zurich

Loading ...

More informations about "AC Immune"

Who is AC Immune? A cutting-edge company with a …

AC Immune is a clinical-stage biopharmaceutical company emerging as a global leader in precision medicine to diagnose, treat and prevent neurodegenerative diseases.See details»

AC Immune - Crunchbase Company Profile & Funding

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials.See details»

Our Teams - AC Immune SA

AC Immune’s leadership team combines a proven track record in entrepreneurial management and world-class scientific thought leadership. The team is committed to excellence and is …See details»

AC Immune - Overview, News & Similar companies | ZoomInfo.com

Dec 2, 2023 View AC Immune (www.acimmune.com) location in Vaud, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

AC Immune S.A. (ACIU-Q) Profile - The Globe and Mail

See the company profile for AC Immune S.A. (ACIU-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»

Annual Report 2022 - AC Immune SA

The World Health Organization recognizes dementia as a global public health priority. Worldwide, there is a new case of dementia every 3 seconds, with an estimated global patient population …See details»

AC Immune - LinkedIn

AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and ...See details»

2021 Annual Report - AC Immune SA

As our organization evolves and grows, our Board of Directors continues to be reinforced. Each member brings a wealth of experience and knowledge well suited to our Company and we …See details»

AC Immune SA – Swiss Biotech

AC Immune SA is a clinical-stage biopharma that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and …See details»

Contacts & Resources - AC Immune SA

Media inquiries:communications@acimmune.com: Phone: +41 21 345 91 21 : Fax: +41 21 345 91 20 . CONTACT FORM. Name. Email. Subject. Comments. Leave this field blank . E-MAIL …See details»

AC Immune Reports Positive Interim Results from Phase 2

Nov 14, 2024 Head of Investor Relations & Corporate Communications Gary Waanders, Ph.D., MBA AC Immune Phone: +41 21 345 91 91 Email: gary.waanders@acimmune.com U.S. …See details»

Pioneering precision medicine - AC Immune SA

Precision medicine is an approach to treating complex diseases. Successfully used in oncology, AC Immune is pioneering precision medicine approaches to address Alzheimer’s and other …See details»

AC Immune Holds Annual General Meeting of Shareholders

Jun 24, 2022 AC Immune SA is a clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including …See details»

Careers - AC Immune SA

Our Team focuses on growth, brand, customer satisfaction, safety and profitability alike, without compromising on ethics and fairness. We prioritize our Team’s needs, support colleagues …See details»

AC Immune SA (ACIU) Stock Price, News, Quote & History - Yahoo …

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative …See details»

Press Release Details - ir.acimmune.com

Sep 17, 2024 About AC Immune SA AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, …See details»

Our first- and best-in-class therapeutic & diagnostic candidates

Future treatment paradigms will combine different therapies at various stages of a disease to engage the underlying co-pathologies. Our suite of non-invasive diagnostic programs targeting …See details»

Press Release Details - AC Immune SA

AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, …See details»

AC Immune's Robust Pipeline focused on neurodegenerative …

Based on our SupraAntigen® and Morphomer® technology platforms, we are advancing one of the industry’s broadest and most diverse clinical-stage pipelines focused on …See details»

linkstock.net © 2022. All rights reserved